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and not from a developmental defect
in the neural circuitry. Furthermore,
expressing orb2 just before training
restored long-term memory whereas
supplying it just after training did not.
Therefore Orb2 is likely to function in
mushroom body gamma neurons
during or shortly after training,
consistent with a role in the formation
of long-term courtship memory.
Because Orb2 is thought to be
a component of the synaptic tag and/or
regulates the expression of tag
components [1], findinganacute role for
orb2 in the gamma neurons of the
mushroom bodies suggests that
courtship (perhaps pheromone)
memories are represented there.
Using the same restoration of orb2
expression approach, it should be easy
to localize courtship memories to
a smaller subset of mushroom body
gamma neurons. Furthermore, if it can
be determined that Orb2 is indeed
localized to thesynapse, activatedOrb2
may ultimately allow visualization of the
memory-relevant individual synapses.
Keleman et al. [1] did not find
a functional distinction between the
Orb2A and B isoforms. It is possible
that they are functionally redundant
but differences may be revealed when
they are expressed at lower level. It
will be important to determine whether
the A and B isoforms function in the
same neurons and in the same way. It
is worth noting that Orb2 belongs to
the CPEB2 protein subfamily and that
mammalian CPEB2-4 proteins bind
sequences distinct from the
cytoplasmic polyadenylation element
[20] and therefore likely stimulate
translation in a different way to
CPEB1/Orb.
The obvious question that arises
when finding a role for an RNA-binding
protein (or transcription factor) in
memory is the identity of the regulated
transcripts. This is especially exciting
for Orb2 because these mRNAs could
reveal the necessary synaptic
components of long-term memory and
perhaps the physical nature of
a synaptic tag. The results of Keleman
et al. [1] are consistent with Orb2 itself
being a component of the tag and
provocatively, Orb2 variants that lack
the prion-like amino terminus retain
function sufficient for the flies to
develop, but they cannot form, or
sustain, long-term memory. It will
therefore be important to determine
whether the Orb2DQ protein localizes
appropriately in neurons and whether
the Orb2 amino terminus mediates
binding to other proteins and/or
whether prion-like Orb2 self-
aggregation is the key to long-lasting
memory [6,7].
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The recognition of phosphatidylserine (PS) on apoptotic cells within tissues
drives both their engulfment and an accompanying anti-inflammatory and
tissue restorative program. Insight into the recognition of this phospholipid
signal by phagocytes is provided by papers describing three new, but
completely different, PS receptors.Donna L. Bratton
and Peter M. Henson
The recognition, engulfment and
recycling of apoptotic cells is offundamental importance in
development, remodeling, tissue
homeostasis, the immune system and
resolution of inflammation. Apoptotic
cells are recognized and phagocytosed
Dispatch
R77by so-called ‘professional’
phagocytes, such as macrophages
and dendritic cells, as well as by
a wide variety of other resident cell
types. A number of ligands have
been reported to be displayed by
apoptotic cells but the appearance of
phosphatidylserine (PS) in the plasma
membrane outer leaflet [1] is an almost
universal recognition ligand. PS on
apoptotic cells is recognized in
a stereospecific manner (L-, but not
D-phosphoserine) and stimulates the
phagocyte both to engulf the apoptotic
cell and to produce anti-inflammatory
mediators, especially TGFb, which
in turn inhibit production of
pro-inflammatory chemokines and
cytokines. Furthermore, oxidation of
the fatty acyl groups appears to
enhance PS recognition, at least by
scavenger family receptors [2]. How PS
arrives at the plasma membrane outer
leaflet during apoptosis is still
a mystery. Various phospholipid
‘flip-floppases’ (flip for inward, and flop
for outward transbilayer movement) or
‘floppases’ have been identified, but
none are universally expressed or
definitively implicated in apoptosis [3].
During cell activation, enhanced
transbilayer flip-flop of PS is thought to
lead to PS exposure, which is then
limited, temporally or spatially, by an
active aminophospholipid translocase
(APLT) that returns PS to the inner
leaflet in living cells [4]. In aging
erythrocytes, PS exposure
accompanies the decline in APLT
function [5]. PS exposure in apoptosis
is associated with dramatic loss of
APLT activity [6], but also with the
possible mixing of the plasma
membrane with internal cell
membranes [7]. Whether designated
proteins or altered lipids or membrane
composition [8] lead to PS exposure in
apoptosis is an open question.
Recognition of the apoptosing cell
by the phagocyte probably involves
‘tethering’ ligands and receptors as
well as ‘tickling’ signals, including
those derived from exposed PS [9].
This paradigm appears conserved
throughout the metazoa. A PS
receptor (PSR), along with
a monoclonal antibody (mAb217)
that was thought to recognize it,
were originally described by Fadok
et al. [10]. However, subsequent
studies in a number of laboratories
have demonstrated that this protein
is primarily found in the nucleus and
probably does not serve as a surfacereceptor at all. It contains a Jumonji
domain (which may suggest
a demethylase function) and is
required for early development. Its
possible participation in other
elements of apoptotic cell clearance
is currently unclear. However,
engagement of phagocytes with
mAb217 does appear to mimic
recognition of PS-exposing apoptotic
cells, though its ligand remains at
large. Of note, while this PSR fell by
the wayside, a number of PS-
recognizing bridge molecules were
described (e.g. Gas6 and protein S,
MFG-E8 and Del-1; Figure 1), which,
acting through their respective
receptors (Mer tyrosine kinase and
av integrins), provided a potential
explanation for PS recognition [11,12].
However, simultaneous efforts by
three separate laboratories, using very
different strategies have now
identified three new PSRs, suggesting
that the paradigm of PS-recognizing
bridge molecules is not the final word.
Using an expression cloning
approach Miyanishi et al. [13] have
identified Tim4 (T-cell immunoglobulin-
and mucin-domain-containing
molecule) as a PSR. Screening of
hybridomas for antibodies that
inhibit apoptotic cell phagocytosis
led to the identification of the Kat5-18
antibody. A retrovirus-mediated
expression cloning system and
a cDNA library from mouse peritoneal
macrophages was used to identify
the antigen as Tim4, a protein
detected in macrophages from many
sites. Heterologous expression of
Tim4 in fibroblasts induced 60% of the
cells to phagocytose apoptotic cells.
Furthermore,Kat5-18blockeduptakeof
apoptotic cells in the thymus and led to
the production of autoantibodies
against double-stranded DNA and
cardiolipin often associated with
defective apoptotic cell uptake. Using
lipid overlays, the immunoglobulin
variable (IgV)-like domain of Tim4 (and
the related family member Tim1) was
shown to bind specifically to PS with
a Kd of about 2 nM.
In a larger context, Tim4 and Tim1
belong to the TIM family proteins,
known for homotypic and heterotypic
binding to each other as well as to
a diverse array of ligands [14].
Miyanishi et al. [13] went on to show
that membrane expression of either
Tim4 or Tim1 results in the binding
of PS-exposing exosomes to the
cells. These findings suggest thatPS exposure detected during
non-apoptotic cell stimulation might
in some cases result from the binding
by Tim4 or Tim1 to such exosomes,
structures known to convey a variety of
signals between cells. Both Tim1 and
Tim4 are associated with T-cell
activation and modulation of cytokine
production from the T helper cell
subsets Th1 and Th2. Furthermore,
Tim1 has been identified as
a susceptibility locus for the
development of atopy and asthma [15].
As such, genetic polymorphisms of
Tim1 and Tim4 and their interactions
with PS-exposing apoptotic cells may
shape the inflammatory milieu,
contributing either to resolution of
inflammation or perhaps toward atopy,
asthma or autoimmunity.
Ravichandran’s laboratory has
previously shown that apoptotic cell
engulfment involves ELMO and
Dock180 acting together as a
guanine nucleotide exchange
factor for the small GTPase Rac.
Using yeast two-hybrid screening to
identify upstream ELMO-interacting
proteins, they identified brain-specific
angiogenesis inhibitor 1 (BAI1),
a seven transmembrane protein
belonging to the adhesion-type
G-protein coupled receptor (GPCR)
family [16] and expressed in brain, bone
marrow, spleenandJ774macrophages.
Expression of BAI1 in fibroblasts
enhanced both binding and engulfment
of apoptotic thymocytes and also
induced PS liposomes. Significantly,
siRNA-mediated knockdown of BAI1
blocked uptake of apoptotic cells
in vitro, and injection of its extracellular
domain prevented uptake in vivo.
Mutational analysis showed that the
a helix of the BAI1 intracellular domain
was necessary and sufficient for ELMO
binding. Furthermore, the trimeric
complex of BAI1–ELMO–Dock180 was
associated with enhanced Rac–GTP
levels and the greatest increase in
apoptotic cell uptake. Genetic
manipulation of the BAI1 extracellular
domain showed that its
thrombospondin type 1 repeats (TSRs)
were required for recognition of PS on
apoptotic cells, and direct binding
to lipid overlays showed stereospecific
binding to PS.
Given the data supporting a role for
thrombospondin 1 as a bridging
molecule that recognizes apoptotic
cells, the finding of TSRs at the
business end of BAI1 is perhaps Nature
repeating herself, and in this instance,




























Figure 1. PS receptors and possible signaling pathways.
The three new PS receptors are depicted in context with some of the other PS-recognizing systems thought to be involved in apoptotic cell
removal. The bridge molecules here are shown with their cognate signaling receptors and may act in part through the ELMO, DOCK180 and
CrkII signaling module that activates Rac. BAI1 was identified specifically by its binding to ELMO. Tim4 has a very short cytoplasmic domain
and most likely needs a partner (at this point unidentified) to signal for uptake. Stabilin-2 acts like a scavenger receptor, a number of which are
already known to bind native and/or oxidized PS, though generally with additional recognition of other anionic phospholipids.providing the PS ‘bridge’ and
downstream signaling unit in one
package. One wonders whether BAI1
may also interact with other tethering
receptors (such as CD36 and av
integrins) that are known to interact
with thrombospondin 1 in the
engulfment process. While there
appears no obvious homolog of BAI1 in
Caenorhabditis elegans (to signal
through its homologs of ELMO and
Dock180), other surface molecules
containing TSRs might serve the same
function in this and other species. The
known role of BAI1 expression in the
blockade of tumor neovascularization
is intriguing, since, in many instances,
apoptotic cell recognition is associated
with angiogenesis. A conserved GPCR
proteolytic cleavage site implicated in
the release of the BAI1 extracellulardomain (termed vasculostatin) and the
subsequent demonstration that the
resulting fragment blocks endothelial
cell avb5-dependent migration and
proliferation [17] raise the question of
whether, under some circumstances,
proteolytic cleavage of BAI1 might
paradoxically inhibit the recognition
and uptake of apoptotic cells, an event
associated with the development of
autoimmunity.
The third PSR recently described is
stabilin-2, a multifunctional receptor
binding a large array of ligands, and
perhaps best known for its scavenger
receptor and endocytic functions.
Park et al. [18] hypothesized that
stabilin-2 might participate in the
removal of aged, PS-exposing red
blood cells (RBCs) and apoptotic
cells. Overexpression of stabilin-2 infibroblasts greatly enhanced both
binding and engulfment of aged, but
not normal, RBCs. Remarkably,
tethered aged RBCs were engulfed
within 2–4 seconds. Furthermore,
both binding and engulfment were
inhibited by an anti-stabilin-2
antibody and by knockdown of the
protein using shRNA, and findings
were similar when apoptotic cells
were used as targets. Recognition
was specific for PS in a stereospecific
manner, though the responsible
molecular sequences are unknown.
Stabilin-2 expression was documented
in human and mouse spleen, human
monocyte-derived macrophages
(HMDMs), alveolar macrophages,
and several macrophage cell lines
but not in J774.1 or Raw246.7 cells,
which are often used in apoptotic
Reproductive Traits: Evidence for
Sexually Selected Sperm
Sperm exhibit extraordinarymorphological divergence yet precise evolutionary
causes often remain elusive. A quantitative genetic study sheds light on
the major role postcopulatory sexual selection could play in determining
sperm size.
Oliver Y. Martin1 and Marco Demont2
Sexual selection arises because
individuals vary in reproductive
success [1]. This variation often
exceeds that in survivorship and sexual
selection is thus a potentially powerful
evolutionary force [2,3]. Classically,
sexual selection is viewed as
comprising competition between
Dispatch
R79cell uptake assays. Knockdown in
HMDMs inhibited phagocytosis
of aged RBC or apoptotic cells.
Stabilin-2, previously associated with
alternative macrophage activation and
with demonstrated localization on
endothelial sinuses of liver, lymph
nodes, spleen and bone marrow [19],
may be a particularly attractive
candidate for clearance of circulating
aged RBC and apoptotic leukocytes.
Finally, Park et al. [18] demonstrate that
engagement of stabilin-2-expressing
cells with either aged RBCs or the
monoclonal antibody resulted in
production of TGFb, a hallmark of the
anti-inflammatory program associated
with recognition of apoptotic cells.
Intriguingly, each of these receptors
seems to use different sequence
structures to recognize PS and these
may be different again from such
recognition domains in the PS-binding
bridge molecules, or the scavenger
receptors, or for that matter, those
of other PS-binding proteins, such as
protein kinase C, annexins or other
coagulation proteins. Until crystal
structures are available, much
remains unknown as to how PS is
recognized by each of these diverse
molecular structures (e.g. whether as
a monomer or multimers patched in
the plasma membrane or oxidized).
The overall redundancy of PS
recognition in response to apoptotic
cells is also noteworthy and leads to
critical questions about the signaling
pathways employed. Of interest here,
genetic analysis in C. elegans
identified signaling molecules but
provided very little evidence for
recognition receptors, suggesting
significant common usage of signal
pathways with perhaps overlap and
redundancy in the receptors. BAI1 was
identified by its interaction with the
ELMO–DOCK180 RacGEF signaling
complex and both the Gas6–MerTK
and MFG-E8–av integrin complexes
have also been shown to at least link
to this complex [11]. Tim4 does not
have a significant or obvious
intracellular signaling domain and
may therefore require a signaling
partner — i.e. serve rather like a
membrane-bound bridge molecule
and/or predominantly as a tethering
ligand. In other words, the finding of
three new PS receptors raises many
new issues, not the least of which is
that it seems unlikely that we have yet
found them all. How do they all
interact? How is the redundancy playedout in different tissues and on different
cells and at different times? Finally, it is
important to note that we can put to
rest the concept that there is a single
phosphatidylserine receptor — there
are clearly many — and the originally
identified PSR needs a new name.
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